Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura E Warren, M.D.

Concepts (132)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms920231432.600 Why?
Mastectomy, Segmental820219561.130 Why?
Breast Neoplasms202023208221.100 Why?
Carcinoma, Intraductal, Noninfiltrating320239491.010 Why?
Central Nervous System Neoplasms220228950.850 Why?
Lymphatic Irradiation420181030.750 Why?
Phyllodes Tumor12020530.720 Why?
Radiotherapy, Adjuvant8202117700.700 Why?
Radiation Oncology320235550.600 Why?
Neoplasm Recurrence, Local6202192390.590 Why?
Lymphedema420185340.530 Why?
Clinical Trials, Phase II as Topic120166290.450 Why?
Telephone120166170.430 Why?
Premenopause1201610330.420 Why?
Carcinoma, Ductal, Breast2202011010.400 Why?
Sentinel Lymph Node Biopsy220187090.390 Why?
Breast Diseases120144430.370 Why?
Lymph Node Excision6201812610.320 Why?
Carcinoma2201723750.290 Why?
Consensus1201629590.290 Why?
Axilla420185950.270 Why?
Evidence-Based Medicine1201636100.240 Why?
Body Mass Index42020127200.220 Why?
Receptor, erbB-26202324160.220 Why?
Patient Participation1201214570.210 Why?
Learning1201217130.210 Why?
Mastectomy, Modified Radical32017620.200 Why?
Patient Education as Topic1201222780.200 Why?
Fluorodeoxyglucose F182202020160.190 Why?
Quality of Health Care1201643710.180 Why?
Mastectomy4202117930.170 Why?
Neoplasm Staging62023110310.160 Why?
Female2820233801940.160 Why?
Decision Making1201238870.150 Why?
Aged, 80 and over102019577760.150 Why?
Retrospective Studies122022774490.150 Why?
Receptors, Progesterone3202010970.150 Why?
Brain Neoplasms2201788630.150 Why?
Chemotherapy, Adjuvant4202334790.150 Why?
Disease-Free Survival3201668950.140 Why?
Ideal Body Weight12016270.140 Why?
Therapeutic Equipoise12016280.140 Why?
Cranial Irradiation120194010.140 Why?
Middle Aged1820232133830.140 Why?
Carcinoma, Lobular120204840.130 Why?
Central Nervous System1202213570.130 Why?
Cisplatin1202116620.120 Why?
Patient Care Planning120209210.120 Why?
Humans3120237443430.120 Why?
Obesity12016127450.120 Why?
Immunocompromised Host120198470.110 Why?
Incidence42022209470.110 Why?
Lymphatic Metastasis3201629240.110 Why?
Efficiency120164620.110 Why?
Combined Modality Therapy3202186420.110 Why?
Thinness120164800.110 Why?
Muscle Fibers, Skeletal120165550.110 Why?
Aged1320211632800.110 Why?
Radiopharmaceuticals2202026450.100 Why?
Radiation Injuries1201911800.100 Why?
Follow-Up Studies52020390500.100 Why?
Estrogen Receptor alpha120155770.100 Why?
Adult1320212140550.090 Why?
Reimbursement Mechanisms120166700.090 Why?
Meningeal Neoplasms1201912410.090 Why?
Radiosurgery1201913290.090 Why?
Patient Selection1202142150.090 Why?
Mammaplasty1201912040.090 Why?
Arm120125890.080 Why?
Treatment Failure1201526180.080 Why?
Pluripotent Stem Cells120167950.080 Why?
Analysis of Variance2201563650.080 Why?
Kaplan-Meier Estimate2201565380.080 Why?
Postmenopause1201624610.070 Why?
Qualitative Research1201626820.070 Why?
Risk Factors52020722900.070 Why?
Treatment Outcome42021631140.070 Why?
Lymph Nodes2201634740.070 Why?
Clinical Clerkship120115320.070 Why?
Neoadjuvant Therapy3202327280.060 Why?
Overweight1201623710.060 Why?
Young Adult52021564300.060 Why?
Educational Measurement1201112100.060 Why?
Survival Rate22017127880.060 Why?
Prognosis32019290630.060 Why?
Antineoplastic Combined Chemotherapy Protocols32023115240.060 Why?
Carcinoma, Squamous Cell1201940340.060 Why?
Insulin Resistance1201638640.050 Why?
Cognition1201967700.050 Why?
Time Factors32018400750.050 Why?
Receptors, Estrogen2202021870.050 Why?
General Surgery1201116360.040 Why?
Prospective Studies42021532880.040 Why?
Skin Neoplasms1201956860.040 Why?
Education, Medical, Graduate1201122910.040 Why?
Maximum Tolerated Dose120218920.040 Why?
Proportional Hazards Models32018123540.040 Why?
Disease Progression12015132840.040 Why?
Randomized Controlled Trials as Topic1201499590.040 Why?
Tomography, X-Ray Computed12020201290.040 Why?
Risk2201896870.030 Why?
Reactive Oxygen Species1202320770.030 Why?
Anthracyclines120172880.030 Why?
Survival Analysis22018102520.030 Why?
Risk Assessment12016233380.030 Why?
Taxoids120176660.030 Why?
Hormones120178890.030 Why?
Neoplasm, Residual120179730.030 Why?
Radiotherapy Dosage1201928790.030 Why?
Cyclophosphamide1201722420.020 Why?
Guidelines as Topic1201814050.020 Why?
Postoperative Complications12012152950.020 Why?
Immunologic Factors1201915800.020 Why?
Hematologic Neoplasms1201918320.020 Why?
Regression Analysis1201564590.020 Why?
Multivariate Analysis12019122450.020 Why?
Diagnosis, Differential12020129590.020 Why?
Odds Ratio1201798490.020 Why?
Pandemics1202383880.010 Why?
United States22023698720.010 Why?
Case-Control Studies12020217460.010 Why?
Feasibility Studies1201150780.010 Why?
Insulin1201665800.010 Why?
Cell Differentiation12016114830.010 Why?
Infant12016351360.010 Why?
Child, Preschool12016410060.010 Why?
Signal Transduction12016234030.010 Why?
HIV Infections12019167180.010 Why?
Diabetes Mellitus, Type 212016117250.010 Why?
Quality of Life12012128040.010 Why?
Adolescent12017857810.010 Why?
Male220193501180.000 Why?
Warren's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (132)
Explore
_
Co-Authors (54)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.